胃癌肝转移外科治疗的临床分析  

Surgical treatment of hepatic metastasis of gastric carcinoma

作　　者：王孟春[1] 薛洪千[1] 许东奎[1] 孙作成[1] 

机构地区：[1]潍坊医学院附属淮坊人民医院普外科,261041

出　　处：《中华普通外科杂志》2003年第4期217-218,共2页Chinese Journal of General Surgery

摘　　要：目的评价胃癌肝转移的外科治疗效果及病理因素对其预后的影响。方法本组834例胃癌患者中共有 91例诊断为肝转移 ,其中 79例为同时性肝转移 ,12例术后发现异时转移 ,共2 1例行胃癌肝转移灶切除术。结果胃癌肝转移灶切除后 1年、3年生存率分别为 6 9%、30 %。单转移灶及异时性转移是其有利的预后因素。 13例肝转移灶有假包膜形成。结论单转移灶及异时转移、肿瘤假包膜形成预示胃癌肝转移切除患者有较好的预后。ObjectiveTo assess the surgical results and implications of clinicopathologic features on the prognosis of patients with hepatic matastases from gastric adenocarcinoma. MethodsNinety one of 834 patients with primary gastric cancer were diagnosed with synchronous ( n =79) or metachronous ( n =12)hepatic metastases. Twenty-one cases underwent hepatectomy for the metastasis. Results The actuarial 1-year, 3-year survival rates after hepatic resection were respectively 69% and 30%. Solitary and metachronous metastases were significant determinants for a favorable prognosis after hepatic resection. Pathologically, tumor pseudomembrane was found in 13 out of 21 patients which was associated with a favorable prognosis. ConclusionsSolitary and metachronous hepatic metastases from gastric cancer should be treated by a surgical approach which confers a good prognosis. The formation of pseudomembrane of the metastatic tumor predicts a favourable postoperative survival.

关 键 词：胃癌 外科治疗 预后 肿瘤转移 手术方式 适应证 

分 类 号：R735.2[医药卫生—肿瘤]